—

The active pharmaceutical ingredient(s) mapped to this medicine. The molecular identifiers below (InChIKey, UNII) come from an automated name→molecule mapping that is not yet curator-verified — shown so it can be checked, not asserted as fact.

Real FDA approval records (Orange Book for small molecules, Purple Book for biologics) linked to this medicine's finished dosage forms. The number of distinct sponsors is a supply-resilience signal — one holder is fragile, many are robust.

A reproducible roll-up of supply fragility, redundancy, and emergency-response levers into a readiness score for normal operations and for a disruption. It scores only what the data supports today and names every factor it cannot yet see — it does not guess.

The supply path from this medicine down to its US supply base, built from VERIFIED FDA records. Each node is shaded by its modeled fragility — cool is resilient, hot is concentrated. Click any node to drill into the facts behind it. Layers we cannot yet see honestly (key inputs, routes) are drawn as explicit gaps, not filled with guesses.